A Cvekl1, F Kashanchi, J N Brady, J Piatigorsky. 1. Laboratory of Molecular and Developmental Biology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892-2730, USA.
Abstract
PURPOSE: To identify proteins that physically interact with Pax-6, a paired domain- and homeodomain (HD)-containing transcription factor that is a key regulator of eye development. METHODS: Protein-protein interactions involving Pax-6, TATA-box-binding protein (TPB), and retinoblastoma protein were studied using affinity chromatography with Pax-6 as ligand, glutathione-S-transferase (GST) pull-down assays, and immunoprecipitations. RESULTS: The authors have shown that Pax-6 is a sequence-specific activator of many crystallin genes, all containing a TATA box, in the lens. Others have shown that lens fiber cell differentiation, characterized by temporally and spatially regulated crystallin gene expression, depends on retinoblastoma protein. In the present study it was shown that Pax-6 interacted with the TBP, the DNA-binding subunit of general transcription complex TFIID. GST pull-down assays indicated that this interaction was mediated by the Pax-6 HD, with a substantial role for its N-terminal arm and first two alpha-helices. The experiments also indicated a binding role for the C-terminal-activation domain of the protein. In addition, the present study showed that the HD of Pax-6 interacted with retinoblastoma protein. Immunoprecipitation experiments confirmed retinoblastoma protein/Pax-6 complexes in lens nuclear extracts. CONCLUSIONS: Blending the present results with those in the literature suggests that Pax-6 and retinoblastoma protein participate in overlapping regulatory pathways controlling epithelial cell division, fiber cell elongation, and crystallin gene expression during lens development.
PURPOSE: To identify proteins that physically interact with Pax-6, a paired domain- and homeodomain (HD)-containing transcription factor that is a key regulator of eye development. METHODS: Protein-protein interactions involving Pax-6, TATA-box-binding protein (TPB), and retinoblastoma protein were studied using affinity chromatography with Pax-6 as ligand, glutathione-S-transferase (GST) pull-down assays, and immunoprecipitations. RESULTS: The authors have shown that Pax-6 is a sequence-specific activator of many crystallin genes, all containing a TATA box, in the lens. Others have shown that lens fiber cell differentiation, characterized by temporally and spatially regulated crystallin gene expression, depends on retinoblastoma protein. In the present study it was shown that Pax-6 interacted with the TBP, the DNA-binding subunit of general transcription complex TFIID. GST pull-down assays indicated that this interaction was mediated by the Pax-6HD, with a substantial role for its N-terminal arm and first two alpha-helices. The experiments also indicated a binding role for the C-terminal-activation domain of the protein. In addition, the present study showed that the HD of Pax-6 interacted with retinoblastoma protein. Immunoprecipitation experiments confirmed retinoblastoma protein/Pax-6 complexes in lens nuclear extracts. CONCLUSIONS: Blending the present results with those in the literature suggests that Pax-6 and retinoblastoma protein participate in overlapping regulatory pathways controlling epithelial cell division, fiber cell elongation, and crystallin gene expression during lens development.
Authors: B Ritz-Laser; B R Gauthier; A Estreicher; A Mamin; T Brun; F Ris; P Salmon; P A Halban; D Trono; J Philippe Journal: Diabetologia Date: 2003-06-03 Impact factor: 10.122
Authors: Ying Yang; Tomás Stopka; Nady Golestaneh; Yan Wang; Kongming Wu; Anping Li; Bharesh K Chauhan; Chun Y Gao; Kveta Cveklová; Melinda K Duncan; Richard G Pestell; Ana B Chepelinsky; Arthur I Skoultchi; Ales Cvekl Journal: EMBO J Date: 2006-05-04 Impact factor: 11.598
Authors: Giuseppe F Pontoriero; Paula Deschamps; Ruth Ashery-Padan; Ryan Wong; Ying Yang; Jiri Zavadil; Ales Cvekl; Shelley Sullivan; Trevor Williams; Judith A West-Mays Journal: Dev Dyn Date: 2008-03 Impact factor: 3.780
Authors: Ohad Shaham; April N Smith; Michael L Robinson; Makoto M Taketo; Richard A Lang; Ruth Ashery-Padan Journal: Development Date: 2009-07-01 Impact factor: 6.868
Authors: Bonnie M Weasner; Brandon Weasner; Stephanie M Deyoung; Scott D Michaels; Justin P Kumar Journal: Dev Biol Date: 2009-05-04 Impact factor: 3.582